nodes	percent_of_prediction	percent_of_DWPC	metapath
Pethidine—ALB—acquired immunodeficiency syndrome	0.23	1	CbGaD
Pethidine—ORM1—Saquinavir—acquired immunodeficiency syndrome	0.0477	0.0823	CbGbCtD
Pethidine—CYP2B6—Efavirenz—acquired immunodeficiency syndrome	0.0317	0.0548	CbGbCtD
Pethidine—CYP2B6—Lopinavir—acquired immunodeficiency syndrome	0.0298	0.0515	CbGbCtD
Pethidine—CYP2B6—Nevirapine—acquired immunodeficiency syndrome	0.0298	0.0515	CbGbCtD
Pethidine—CYP2B6—Amprenavir—acquired immunodeficiency syndrome	0.027	0.0466	CbGbCtD
Pethidine—CYP2B6—Nelfinavir—acquired immunodeficiency syndrome	0.0226	0.0391	CbGbCtD
Pethidine—CYP2B6—Ritonavir—acquired immunodeficiency syndrome	0.0205	0.0353	CbGbCtD
Pethidine—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.0202	0.0348	CbGbCtD
Pethidine—ALB—Saquinavir—acquired immunodeficiency syndrome	0.02	0.0346	CbGbCtD
Pethidine—ALB—Zidovudine—acquired immunodeficiency syndrome	0.0192	0.0332	CbGbCtD
Pethidine—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.019	0.0328	CbGbCtD
Pethidine—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.0172	0.0296	CbGbCtD
Pethidine—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.0172	0.0296	CbGbCtD
Pethidine—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0153	0.0265	CbGbCtD
Pethidine—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.0148	0.0256	CbGbCtD
Pethidine—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0144	0.0249	CbGbCtD
Pethidine—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0144	0.0249	CbGbCtD
Pethidine—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.0144	0.0248	CbGbCtD
Pethidine—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.013	0.0225	CbGbCtD
Pethidine—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.013	0.0225	CbGbCtD
Pethidine—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.013	0.0224	CbGbCtD
Pethidine—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.013	0.0224	CbGbCtD
Pethidine—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.0125	0.0215	CbGbCtD
Pethidine—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.0113	0.0194	CbGbCtD
Pethidine—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.0109	0.0189	CbGbCtD
Pethidine—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.00988	0.0171	CbGbCtD
Pethidine—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.00988	0.0171	CbGbCtD
Pethidine—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.00975	0.0168	CbGbCtD
Pethidine—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00917	0.0158	CbGbCtD
Pethidine—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00917	0.0158	CbGbCtD
Pethidine—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.00829	0.0143	CbGbCtD
Pethidine—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00829	0.0143	CbGbCtD
Pethidine—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00716	0.0124	CbGbCtD
Pethidine—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00695	0.012	CbGbCtD
Pethidine—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00628	0.0109	CbGbCtD
Pethidine—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00628	0.0109	CbGbCtD
Pethidine—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00602	0.0104	CbGbCtD
Pethidine—GRIN2C—nerve—acquired immunodeficiency syndrome	0.00473	0.077	CbGeAlD
Pethidine—GRIN2B—nerve—acquired immunodeficiency syndrome	0.00374	0.0609	CbGeAlD
Pethidine—ORM1—saliva—acquired immunodeficiency syndrome	0.00337	0.0549	CbGeAlD
Pethidine—GRIN2A—nerve—acquired immunodeficiency syndrome	0.00327	0.0532	CbGeAlD
Pethidine—OPRM1—nerve—acquired immunodeficiency syndrome	0.00199	0.0324	CbGeAlD
Pethidine—SLC6A3—nerve—acquired immunodeficiency syndrome	0.0018	0.0294	CbGeAlD
Pethidine—SLC6A2—nerve—acquired immunodeficiency syndrome	0.00145	0.0237	CbGeAlD
Pethidine—SLC6A4—blood plasma—acquired immunodeficiency syndrome	0.00125	0.0203	CbGeAlD
Pethidine—GRIN2D—spinal cord—acquired immunodeficiency syndrome	0.00117	0.0191	CbGeAlD
Pethidine—GRIN2C—nervous system—acquired immunodeficiency syndrome	0.00106	0.0173	CbGeAlD
Pethidine—GRIN1—spinal cord—acquired immunodeficiency syndrome	0.00105	0.017	CbGeAlD
Pethidine—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.00104	0.0169	CbGeAlD
Pethidine—GRIN2C—central nervous system—acquired immunodeficiency syndrome	0.00102	0.0167	CbGeAlD
Pethidine—GRIN2B—spinal cord—acquired immunodeficiency syndrome	0.000998	0.0163	CbGeAlD
Pethidine—GRIN2D—nervous system—acquired immunodeficiency syndrome	0.000989	0.0161	CbGeAlD
Pethidine—GRIN2D—central nervous system—acquired immunodeficiency syndrome	0.000952	0.0155	CbGeAlD
Pethidine—GRIN1—nervous system—acquired immunodeficiency syndrome	0.000882	0.0144	CbGeAlD
Pethidine—GRIN2A—spinal cord—acquired immunodeficiency syndrome	0.000872	0.0142	CbGeAlD
Pethidine—GRIN1—central nervous system—acquired immunodeficiency syndrome	0.000849	0.0138	CbGeAlD
Pethidine—GRIN2B—nervous system—acquired immunodeficiency syndrome	0.000841	0.0137	CbGeAlD
Pethidine—GRIN2A—vagina—acquired immunodeficiency syndrome	0.000839	0.0137	CbGeAlD
Pethidine—GRIN2C—brain—acquired immunodeficiency syndrome	0.000813	0.0132	CbGeAlD
Pethidine—CYP2B6—blood plasma—acquired immunodeficiency syndrome	0.000811	0.0132	CbGeAlD
Pethidine—GRIN2B—central nervous system—acquired immunodeficiency syndrome	0.00081	0.0132	CbGeAlD
Pethidine—GRIN2D—brain—acquired immunodeficiency syndrome	0.000756	0.0123	CbGeAlD
Pethidine—GRIN2A—nervous system—acquired immunodeficiency syndrome	0.000735	0.012	CbGeAlD
Pethidine—GRIN2A—central nervous system—acquired immunodeficiency syndrome	0.000708	0.0115	CbGeAlD
Pethidine—GRIN1—brain—acquired immunodeficiency syndrome	0.000674	0.011	CbGeAlD
Pethidine—GRIN2B—brain—acquired immunodeficiency syndrome	0.000643	0.0105	CbGeAlD
Pethidine—OPRK1—nervous system—acquired immunodeficiency syndrome	0.000628	0.0102	CbGeAlD
Pethidine—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000612	0.00997	CbGeAlD
Pethidine—OPRK1—central nervous system—acquired immunodeficiency syndrome	0.000605	0.00985	CbGeAlD
Pethidine—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000602	0.00981	CbGeAlD
Pethidine—GRIN2A—brain—acquired immunodeficiency syndrome	0.000562	0.00915	CbGeAlD
Pethidine—OPRM1—blood—acquired immunodeficiency syndrome	0.00055	0.00896	CbGeAlD
Pethidine—ORM1—blood—acquired immunodeficiency syndrome	0.000537	0.00875	CbGeAlD
Pethidine—OPRM1—spinal cord—acquired immunodeficiency syndrome	0.00053	0.00864	CbGeAlD
Pethidine—ORM1—bone marrow—acquired immunodeficiency syndrome	0.00052	0.00847	CbGeAlD
Pethidine—ORM1—spinal cord—acquired immunodeficiency syndrome	0.000518	0.00843	CbGeAlD
Pethidine—SLC6A3—spinal cord—acquired immunodeficiency syndrome	0.000481	0.00784	CbGeAlD
Pethidine—SLC6A4—digestive system—acquired immunodeficiency syndrome	0.000481	0.00783	CbGeAlD
Pethidine—OPRK1—brain—acquired immunodeficiency syndrome	0.00048	0.00782	CbGeAlD
Pethidine—ORM1—lung—acquired immunodeficiency syndrome	0.000471	0.00767	CbGeAlD
Pethidine—SLC6A4—blood—acquired immunodeficiency syndrome	0.000458	0.00745	CbGeAlD
Pethidine—OPRM1—nervous system—acquired immunodeficiency syndrome	0.000447	0.00728	CbGeAlD
Pethidine—SLC6A4—spinal cord—acquired immunodeficiency syndrome	0.000441	0.00718	CbGeAlD
Pethidine—SLC6A3—lung—acquired immunodeficiency syndrome	0.000438	0.00713	CbGeAlD
Pethidine—ORM1—nervous system—acquired immunodeficiency syndrome	0.000436	0.0071	CbGeAlD
Pethidine—OPRM1—central nervous system—acquired immunodeficiency syndrome	0.00043	0.00701	CbGeAlD
Pethidine—ORM1—central nervous system—acquired immunodeficiency syndrome	0.00042	0.00684	CbGeAlD
Pethidine—SLC6A3—nervous system—acquired immunodeficiency syndrome	0.000406	0.0066	CbGeAlD
Pethidine—SLC6A4—lung—acquired immunodeficiency syndrome	0.000401	0.00654	CbGeAlD
Pethidine—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.000398	0.00648	CbGeAlD
Pethidine—GRIN1—EPHB-mediated forward signaling—ACTG1—acquired immunodeficiency syndrome	0.000396	0.0468	CbGpPWpGaD
Pethidine—SLC6A3—central nervous system—acquired immunodeficiency syndrome	0.00039	0.00636	CbGeAlD
Pethidine—CYP2B6—skin of body—acquired immunodeficiency syndrome	0.00039	0.00635	CbGeAlD
Pethidine—GRIN2B—EPHB-mediated forward signaling—ACTG1—acquired immunodeficiency syndrome	0.000386	0.0456	CbGpPWpGaD
Pethidine—CYP2C19—blood—acquired immunodeficiency syndrome	0.000379	0.00618	CbGeAlD
Pethidine—SLC6A4—nervous system—acquired immunodeficiency syndrome	0.000372	0.00605	CbGeAlD
Pethidine—SLC6A4—central nervous system—acquired immunodeficiency syndrome	0.000358	0.00583	CbGeAlD
Pethidine—SLC6A2—lung—acquired immunodeficiency syndrome	0.000353	0.00575	CbGeAlD
Pethidine—CYP2C19—vagina—acquired immunodeficiency syndrome	0.000352	0.00573	CbGeAlD
Pethidine—OPRM1—brain—acquired immunodeficiency syndrome	0.000342	0.00556	CbGeAlD
Pethidine—SLC6A2—nervous system—acquired immunodeficiency syndrome	0.000327	0.00533	CbGeAlD
Pethidine—ORM1—lymph node—acquired immunodeficiency syndrome	0.000322	0.00525	CbGeAlD
Pethidine—CYP2B6—lymphoid tissue—acquired immunodeficiency syndrome	0.000316	0.00514	CbGeAlD
Pethidine—SLC6A2—central nervous system—acquired immunodeficiency syndrome	0.000315	0.00513	CbGeAlD
Pethidine—CYP2B6—digestive system—acquired immunodeficiency syndrome	0.000312	0.00508	CbGeAlD
Pethidine—SLC6A3—brain—acquired immunodeficiency syndrome	0.00031	0.00505	CbGeAlD
Pethidine—CYP2B6—blood—acquired immunodeficiency syndrome	0.000297	0.00484	CbGeAlD
Pethidine—ALB—brain—acquired immunodeficiency syndrome	0.000292	0.00476	CbGeAlD
Pethidine—Constipation—Stavudine—acquired immunodeficiency syndrome	0.000288	0.00237	CcSEcCtD
Pethidine—Shock—Zidovudine—acquired immunodeficiency syndrome	0.000288	0.00237	CcSEcCtD
Pethidine—Feeling abnormal—Nevirapine—acquired immunodeficiency syndrome	0.000287	0.00236	CcSEcCtD
Pethidine—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.000286	0.00235	CcSEcCtD
Pethidine—SLC6A4—brain—acquired immunodeficiency syndrome	0.000284	0.00463	CbGeAlD
Pethidine—Vertigo—Efavirenz—acquired immunodeficiency syndrome	0.000283	0.00233	CcSEcCtD
Pethidine—Anxiety—Indinavir—acquired immunodeficiency syndrome	0.000283	0.00233	CcSEcCtD
Pethidine—Hyperhidrosis—Zidovudine—acquired immunodeficiency syndrome	0.000283	0.00233	CcSEcCtD
Pethidine—Syncope—Efavirenz—acquired immunodeficiency syndrome	0.000283	0.00233	CcSEcCtD
Pethidine—ALB—lymph node—acquired immunodeficiency syndrome	0.000282	0.0046	CbGeAlD
Pethidine—Tremor—Delavirdine—acquired immunodeficiency syndrome	0.000282	0.00232	CcSEcCtD
Pethidine—Anorexia—Zidovudine—acquired immunodeficiency syndrome	0.000279	0.0023	CcSEcCtD
Pethidine—Palpitations—Efavirenz—acquired immunodeficiency syndrome	0.000278	0.00229	CcSEcCtD
Pethidine—Feeling abnormal—Nelfinavir—acquired immunodeficiency syndrome	0.000278	0.00229	CcSEcCtD
Pethidine—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.000278	0.00229	CcSEcCtD
Pethidine—Dry mouth—Indinavir—acquired immunodeficiency syndrome	0.000278	0.00228	CcSEcCtD
Pethidine—Agitation—Delavirdine—acquired immunodeficiency syndrome	0.000277	0.00228	CcSEcCtD
Pethidine—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.000277	0.00228	CcSEcCtD
Pethidine—Loss of consciousness—Efavirenz—acquired immunodeficiency syndrome	0.000277	0.00228	CcSEcCtD
Pethidine—CYP2B6—vagina—acquired immunodeficiency syndrome	0.000275	0.00448	CbGeAlD
Pethidine—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.000274	0.00226	CcSEcCtD
Pethidine—Feeling abnormal—Abacavir—acquired immunodeficiency syndrome	0.000273	0.00225	CcSEcCtD
Pethidine—Convulsion—Efavirenz—acquired immunodeficiency syndrome	0.000273	0.00225	CcSEcCtD
Pethidine—Oedema—Indinavir—acquired immunodeficiency syndrome	0.000272	0.00224	CcSEcCtD
Pethidine—Anaphylactic shock—Indinavir—acquired immunodeficiency syndrome	0.000272	0.00224	CcSEcCtD
Pethidine—Hypertension—Efavirenz—acquired immunodeficiency syndrome	0.000272	0.00224	CcSEcCtD
Pethidine—Vertigo—Delavirdine—acquired immunodeficiency syndrome	0.000271	0.00223	CcSEcCtD
Pethidine—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.00027	0.00223	CcSEcCtD
Pethidine—Syncope—Delavirdine—acquired immunodeficiency syndrome	0.00027	0.00222	CcSEcCtD
Pethidine—Erythema—Saquinavir—acquired immunodeficiency syndrome	0.000268	0.00221	CcSEcCtD
Pethidine—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.000268	0.00221	CcSEcCtD
Pethidine—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000268	0.00221	CcSEcCtD
Pethidine—Muscle spasms—Ritonavir—acquired immunodeficiency syndrome	0.000268	0.00221	CcSEcCtD
Pethidine—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.000268	0.00221	CcSEcCtD
Pethidine—Shock—Indinavir—acquired immunodeficiency syndrome	0.000268	0.0022	CcSEcCtD
Pethidine—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.000267	0.0022	CcSEcCtD
Pethidine—Anxiety—Efavirenz—acquired immunodeficiency syndrome	0.000267	0.0022	CcSEcCtD
Pethidine—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000266	0.00219	CcSEcCtD
Pethidine—Palpitations—Delavirdine—acquired immunodeficiency syndrome	0.000266	0.00219	CcSEcCtD
Pethidine—Loss of consciousness—Delavirdine—acquired immunodeficiency syndrome	0.000265	0.00218	CcSEcCtD
Pethidine—Insomnia—Zidovudine—acquired immunodeficiency syndrome	0.000265	0.00218	CcSEcCtD
Pethidine—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.000263	0.00217	CcSEcCtD
Pethidine—Hyperhidrosis—Indinavir—acquired immunodeficiency syndrome	0.000263	0.00217	CcSEcCtD
Pethidine—Dry mouth—Efavirenz—acquired immunodeficiency syndrome	0.000262	0.00216	CcSEcCtD
Pethidine—Tremor—Ritonavir—acquired immunodeficiency syndrome	0.000261	0.00215	CcSEcCtD
Pethidine—CYP2B6—lung—acquired immunodeficiency syndrome	0.00026	0.00424	CbGeAlD
Pethidine—Hypertension—Delavirdine—acquired immunodeficiency syndrome	0.00026	0.00214	CcSEcCtD
Pethidine—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.00026	0.00214	CcSEcCtD
Pethidine—Anorexia—Indinavir—acquired immunodeficiency syndrome	0.000259	0.00213	CcSEcCtD
Pethidine—Confusional state—Efavirenz—acquired immunodeficiency syndrome	0.000259	0.00213	CcSEcCtD
Pethidine—Muscle spasms—Saquinavir—acquired immunodeficiency syndrome	0.000258	0.00212	CcSEcCtD
Pethidine—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.000257	0.00211	CcSEcCtD
Pethidine—Agitation—Ritonavir—acquired immunodeficiency syndrome	0.000256	0.00211	CcSEcCtD
Pethidine—Erythema—Lamivudine—acquired immunodeficiency syndrome	0.000256	0.00211	CcSEcCtD
Pethidine—Anxiety—Delavirdine—acquired immunodeficiency syndrome	0.000256	0.0021	CcSEcCtD
Pethidine—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	0.000254	0.00209	CcSEcCtD
Pethidine—Shock—Efavirenz—acquired immunodeficiency syndrome	0.000253	0.00208	CcSEcCtD
Pethidine—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000253	0.00208	CcSEcCtD
Pethidine—Tremor—Saquinavir—acquired immunodeficiency syndrome	0.000251	0.00207	CcSEcCtD
Pethidine—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.000251	0.00207	CcSEcCtD
Pethidine—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.000251	0.00207	CcSEcCtD
Pethidine—Vertigo—Ritonavir—acquired immunodeficiency syndrome	0.00025	0.00206	CcSEcCtD
Pethidine—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.00025	0.00206	CcSEcCtD
Pethidine—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.00025	0.00206	CcSEcCtD
Pethidine—SLC6A2—brain—acquired immunodeficiency syndrome	0.00025	0.00407	CbGeAlD
Pethidine—Syncope—Ritonavir—acquired immunodeficiency syndrome	0.00025	0.00206	CcSEcCtD
Pethidine—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000249	0.00205	CcSEcCtD
Pethidine—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.000249	0.00205	CcSEcCtD
Pethidine—Confusional state—Delavirdine—acquired immunodeficiency syndrome	0.000248	0.00204	CcSEcCtD
Pethidine—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000248	0.00204	CcSEcCtD
Pethidine—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000247	0.00203	CcSEcCtD
Pethidine—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000247	0.00203	CcSEcCtD
Pethidine—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.000247	0.00203	CcSEcCtD
Pethidine—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.000246	0.00203	CcSEcCtD
Pethidine—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000246	0.00203	CcSEcCtD
Pethidine—Muscle spasms—Lamivudine—acquired immunodeficiency syndrome	0.000246	0.00203	CcSEcCtD
Pethidine—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.000246	0.00202	CcSEcCtD
Pethidine—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000245	0.00202	CcSEcCtD
Pethidine—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.000245	0.00202	CcSEcCtD
Pethidine—Rash—Didanosine—acquired immunodeficiency syndrome	0.000244	0.00201	CcSEcCtD
Pethidine—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000244	0.00201	CcSEcCtD
Pethidine—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000244	0.00201	CcSEcCtD
Pethidine—Headache—Didanosine—acquired immunodeficiency syndrome	0.000243	0.002	CcSEcCtD
Pethidine—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000242	0.00199	CcSEcCtD
Pethidine—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000242	0.00199	CcSEcCtD
Pethidine—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000242	0.00199	CcSEcCtD
Pethidine—SLC6A2—lymph node—acquired immunodeficiency syndrome	0.000242	0.00394	CbGeAlD
Pethidine—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000242	0.00199	CcSEcCtD
Pethidine—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000242	0.00199	CcSEcCtD
Pethidine—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000241	0.00198	CcSEcCtD
Pethidine—CYP2B6—nervous system—acquired immunodeficiency syndrome	0.000241	0.00393	CbGeAlD
Pethidine—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.000241	0.00198	CcSEcCtD
Pethidine—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000241	0.00198	CcSEcCtD
Pethidine—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000241	0.00198	CcSEcCtD
Pethidine—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.00024	0.00198	CcSEcCtD
Pethidine—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.00024	0.00197	CcSEcCtD
Pethidine—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000239	0.00197	CcSEcCtD
Pethidine—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000238	0.00196	CcSEcCtD
Pethidine—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000238	0.00196	CcSEcCtD
Pethidine—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000238	0.00196	CcSEcCtD
Pethidine—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000237	0.00195	CcSEcCtD
Pethidine—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000236	0.00195	CcSEcCtD
Pethidine—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000236	0.00194	CcSEcCtD
Pethidine—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000235	0.00383	CbGeAlD
Pethidine—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000235	0.00193	CcSEcCtD
Pethidine—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000234	0.00193	CcSEcCtD
Pethidine—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000233	0.00192	CcSEcCtD
Pethidine—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000233	0.00191	CcSEcCtD
Pethidine—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000232	0.00191	CcSEcCtD
Pethidine—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000232	0.00191	CcSEcCtD
Pethidine—CYP2B6—central nervous system—acquired immunodeficiency syndrome	0.000232	0.00378	CbGeAlD
Pethidine—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000232	0.00191	CcSEcCtD
Pethidine—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000232	0.00377	CbGeAlD
Pethidine—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000232	0.00191	CcSEcCtD
Pethidine—Nausea—Didanosine—acquired immunodeficiency syndrome	0.00023	0.0019	CcSEcCtD
Pethidine—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.00023	0.00189	CcSEcCtD
Pethidine—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.00023	0.00189	CcSEcCtD
Pethidine—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.00023	0.00189	CcSEcCtD
Pethidine—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000229	0.00189	CcSEcCtD
Pethidine—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000229	0.00188	CcSEcCtD
Pethidine—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000228	0.00187	CcSEcCtD
Pethidine—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000227	0.00187	CcSEcCtD
Pethidine—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000225	0.00185	CcSEcCtD
Pethidine—CYP3A4—blood—acquired immunodeficiency syndrome	0.000224	0.00365	CbGeAlD
Pethidine—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000224	0.00185	CcSEcCtD
Pethidine—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000224	0.00184	CcSEcCtD
Pethidine—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000224	0.00184	CcSEcCtD
Pethidine—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000223	0.00184	CcSEcCtD
Pethidine—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000223	0.00184	CcSEcCtD
Pethidine—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000223	0.00183	CcSEcCtD
Pethidine—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000222	0.00183	CcSEcCtD
Pethidine—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000222	0.00183	CcSEcCtD
Pethidine—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000222	0.00183	CcSEcCtD
Pethidine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000222	0.00182	CcSEcCtD
Pethidine—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000221	0.00182	CcSEcCtD
Pethidine—CYP2D6—blood—acquired immunodeficiency syndrome	0.000221	0.00359	CbGeAlD
Pethidine—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.00022	0.00181	CcSEcCtD
Pethidine—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.00022	0.00181	CcSEcCtD
Pethidine—Rash—Nevirapine—acquired immunodeficiency syndrome	0.00022	0.00181	CcSEcCtD
Pethidine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.00022	0.00181	CcSEcCtD
Pethidine—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000219	0.0018	CcSEcCtD
Pethidine—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000219	0.0018	CcSEcCtD
Pethidine—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000219	0.0018	CcSEcCtD
Pethidine—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000218	0.0018	CcSEcCtD
Pethidine—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000217	0.00179	CcSEcCtD
Pethidine—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000217	0.00178	CcSEcCtD
Pethidine—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000216	0.00178	CcSEcCtD
Pethidine—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000215	0.00177	CcSEcCtD
Pethidine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000215	0.00177	CcSEcCtD
Pethidine—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000214	0.00176	CcSEcCtD
Pethidine—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000214	0.00176	CcSEcCtD
Pethidine—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000213	0.00175	CcSEcCtD
Pethidine—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000213	0.00175	CcSEcCtD
Pethidine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000213	0.00175	CcSEcCtD
Pethidine—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000213	0.00175	CcSEcCtD
Pethidine—Rash—Stavudine—acquired immunodeficiency syndrome	0.000212	0.00175	CcSEcCtD
Pethidine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000212	0.00175	CcSEcCtD
Pethidine—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000212	0.00174	CcSEcCtD
Pethidine—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000212	0.00174	CcSEcCtD
Pethidine—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000212	0.00174	CcSEcCtD
Pethidine—Headache—Stavudine—acquired immunodeficiency syndrome	0.000211	0.00174	CcSEcCtD
Pethidine—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000211	0.00174	CcSEcCtD
Pethidine—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000211	0.00173	CcSEcCtD
Pethidine—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.00021	0.00173	CcSEcCtD
Pethidine—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.00021	0.00173	CcSEcCtD
Pethidine—Rash—Abacavir—acquired immunodeficiency syndrome	0.000209	0.00172	CcSEcCtD
Pethidine—SLC6A4—Circadian rythm related genes—CARTPT—acquired immunodeficiency syndrome	0.000209	0.0247	CbGpPWpGaD
Pethidine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000209	0.00172	CcSEcCtD
Pethidine—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000209	0.00172	CcSEcCtD
Pethidine—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000209	0.00172	CcSEcCtD
Pethidine—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000209	0.00172	CcSEcCtD
Pethidine—Headache—Abacavir—acquired immunodeficiency syndrome	0.000208	0.00171	CcSEcCtD
Pethidine—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000207	0.0017	CcSEcCtD
Pethidine—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000207	0.0017	CcSEcCtD
Pethidine—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000206	0.00169	CcSEcCtD
Pethidine—ALB—FOXA2 and FOXA3 transcription factor networks—TAT—acquired immunodeficiency syndrome	0.000206	0.0243	CbGpPWpGaD
Pethidine—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000206	0.00169	CcSEcCtD
Pethidine—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000205	0.00168	CcSEcCtD
Pethidine—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000204	0.00168	CcSEcCtD
Pethidine—OPRK1—Peptide GPCRs—ACKR1—acquired immunodeficiency syndrome	0.000204	0.0241	CbGpPWpGaD
Pethidine—GRIN1—EPH-Ephrin signaling—ACTG1—acquired immunodeficiency syndrome	0.000204	0.0241	CbGpPWpGaD
Pethidine—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000203	0.00167	CcSEcCtD
Pethidine—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000202	0.00166	CcSEcCtD
Pethidine—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000202	0.00166	CcSEcCtD
Pethidine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000201	0.00165	CcSEcCtD
Pethidine—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.0002	0.00165	CcSEcCtD
Pethidine—Nausea—Stavudine—acquired immunodeficiency syndrome	0.0002	0.00165	CcSEcCtD
Pethidine—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000199	0.00164	CcSEcCtD
Pethidine—GRIN2B—EPH-Ephrin signaling—ACTG1—acquired immunodeficiency syndrome	0.000199	0.0235	CbGpPWpGaD
Pethidine—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000198	0.00163	CcSEcCtD
Pethidine—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000198	0.00163	CcSEcCtD
Pethidine—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000197	0.00162	CcSEcCtD
Pethidine—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000195	0.00161	CcSEcCtD
Pethidine—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000195	0.00161	CcSEcCtD
Pethidine—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000195	0.00161	CcSEcCtD
Pethidine—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000195	0.0016	CcSEcCtD
Pethidine—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000195	0.0016	CcSEcCtD
Pethidine—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000193	0.00159	CcSEcCtD
Pethidine—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000193	0.00158	CcSEcCtD
Pethidine—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.00019	0.00157	CcSEcCtD
Pethidine—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000189	0.00156	CcSEcCtD
Pethidine—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000189	0.00155	CcSEcCtD
Pethidine—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000187	0.00154	CcSEcCtD
Pethidine—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000187	0.00154	CcSEcCtD
Pethidine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000186	0.00153	CcSEcCtD
Pethidine—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000186	0.00153	CcSEcCtD
Pethidine—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000184	0.00152	CcSEcCtD
Pethidine—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000184	0.00152	CcSEcCtD
Pethidine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000184	0.00152	CcSEcCtD
Pethidine—CYP2B6—brain—acquired immunodeficiency syndrome	0.000184	0.003	CbGeAlD
Pethidine—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000183	0.00151	CcSEcCtD
Pethidine—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000182	0.00296	CbGeAlD
Pethidine—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000182	0.0015	CcSEcCtD
Pethidine—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000182	0.00149	CcSEcCtD
Pethidine—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000181	0.00149	CcSEcCtD
Pethidine—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000181	0.00149	CcSEcCtD
Pethidine—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.00018	0.00148	CcSEcCtD
Pethidine—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.00018	0.00148	CcSEcCtD
Pethidine—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000179	0.00292	CbGeAlD
Pethidine—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000179	0.00147	CcSEcCtD
Pethidine—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000177	0.00145	CcSEcCtD
Pethidine—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000175	0.00285	CbGeAlD
Pethidine—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000174	0.00143	CcSEcCtD
Pethidine—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000174	0.00143	CcSEcCtD
Pethidine—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000174	0.00143	CcSEcCtD
Pethidine—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000173	0.00142	CcSEcCtD
Pethidine—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000172	0.00281	CbGeAlD
Pethidine—OPRM1—Peptide GPCRs—ACKR1—acquired immunodeficiency syndrome	0.000172	0.0204	CbGpPWpGaD
Pethidine—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000172	0.00142	CcSEcCtD
Pethidine—Rash—Indinavir—acquired immunodeficiency syndrome	0.000172	0.00141	CcSEcCtD
Pethidine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000171	0.00141	CcSEcCtD
Pethidine—Headache—Indinavir—acquired immunodeficiency syndrome	0.00017	0.0014	CcSEcCtD
Pethidine—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.00017	0.0014	CcSEcCtD
Pethidine—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000168	0.00138	CcSEcCtD
Pethidine—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000166	0.00137	CcSEcCtD
Pethidine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000163	0.00135	CcSEcCtD
Pethidine—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000163	0.00134	CcSEcCtD
Pethidine—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000163	0.00134	CcSEcCtD
Pethidine—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000162	0.00133	CcSEcCtD
Pethidine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000162	0.00133	CcSEcCtD
Pethidine—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000162	0.00133	CcSEcCtD
Pethidine—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000161	0.00133	CcSEcCtD
Pethidine—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000161	0.00133	CcSEcCtD
Pethidine—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000161	0.00132	CcSEcCtD
Pethidine—OPRK1—Peptide ligand-binding receptors—CCL3L1—acquired immunodeficiency syndrome	0.000158	0.0187	CbGpPWpGaD
Pethidine—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000157	0.00129	CcSEcCtD
Pethidine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000156	0.00129	CcSEcCtD
Pethidine—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000155	0.00128	CcSEcCtD
Pethidine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000155	0.00128	CcSEcCtD
Pethidine—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000155	0.00127	CcSEcCtD
Pethidine—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000154	0.00127	CcSEcCtD
Pethidine—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000154	0.00127	CcSEcCtD
Pethidine—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000153	0.00126	CcSEcCtD
Pethidine—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.00015	0.00124	CcSEcCtD
Pethidine—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.00015	0.00123	CcSEcCtD
Pethidine—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000148	0.00122	CcSEcCtD
Pethidine—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000146	0.0012	CcSEcCtD
Pethidine—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000145	0.00119	CcSEcCtD
Pethidine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000145	0.00119	CcSEcCtD
Pethidine—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000143	0.00118	CcSEcCtD
Pethidine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000143	0.00118	CcSEcCtD
Pethidine—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000143	0.00117	CcSEcCtD
Pethidine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000139	0.00115	CcSEcCtD
Pethidine—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000138	0.00114	CcSEcCtD
Pethidine—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000138	0.00114	CcSEcCtD
Pethidine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000138	0.00114	CcSEcCtD
Pethidine—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000137	0.00113	CcSEcCtD
Pethidine—CYP2D6—brain—acquired immunodeficiency syndrome	0.000137	0.00223	CbGeAlD
Pethidine—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000135	0.00111	CcSEcCtD
Pethidine—OPRM1—Peptide ligand-binding receptors—CCL3L1—acquired immunodeficiency syndrome	0.000134	0.0158	CbGpPWpGaD
Pethidine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000133	0.00109	CcSEcCtD
Pethidine—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000132	0.00108	CcSEcCtD
Pethidine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000132	0.00108	CcSEcCtD
Pethidine—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000131	0.00108	CcSEcCtD
Pethidine—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.00013	0.00107	CcSEcCtD
Pethidine—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000124	0.00102	CcSEcCtD
Pethidine—OPRK1—Peptide GPCRs—CCR2—acquired immunodeficiency syndrome	0.000114	0.0135	CbGpPWpGaD
Pethidine—GRIN1—Spinal Cord Injury—CCR2—acquired immunodeficiency syndrome	0.000109	0.0129	CbGpPWpGaD
Pethidine—OPRK1—Peptide GPCRs—CXCR4—acquired immunodeficiency syndrome	0.000107	0.0127	CbGpPWpGaD
Pethidine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.000106	0.0125	CbGpPWpGaD
Pethidine—OPRM1—Peptide GPCRs—CCR2—acquired immunodeficiency syndrome	9.62e-05	0.0114	CbGpPWpGaD
Pethidine—OPRK1—Peptide ligand-binding receptors—ACKR1—acquired immunodeficiency syndrome	9.59e-05	0.0113	CbGpPWpGaD
Pethidine—OPRM1—Peptide GPCRs—CXCR4—acquired immunodeficiency syndrome	9.05e-05	0.0107	CbGpPWpGaD
Pethidine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	8.97e-05	0.0106	CbGpPWpGaD
Pethidine—OPRK1—Peptide ligand-binding receptors—CCL4—acquired immunodeficiency syndrome	8.67e-05	0.0102	CbGpPWpGaD
Pethidine—OPRM1—Peptide ligand-binding receptors—ACKR1—acquired immunodeficiency syndrome	8.1e-05	0.00957	CbGpPWpGaD
Pethidine—OPRK1—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	8.08e-05	0.00955	CbGpPWpGaD
Pethidine—OPRM1—IL4-mediated signaling events—IL10—acquired immunodeficiency syndrome	7.9e-05	0.00933	CbGpPWpGaD
Pethidine—OPRM1—IL4-mediated signaling events—CD40LG—acquired immunodeficiency syndrome	7.9e-05	0.00933	CbGpPWpGaD
Pethidine—OPRM1—IL4-mediated signaling events—IL4—acquired immunodeficiency syndrome	7.69e-05	0.00908	CbGpPWpGaD
Pethidine—GRIN1—Spinal Cord Injury—IL4—acquired immunodeficiency syndrome	7.59e-05	0.00896	CbGpPWpGaD
Pethidine—GRIN1—Axon guidance—ACTG1—acquired immunodeficiency syndrome	7.57e-05	0.00894	CbGpPWpGaD
Pethidine—GRIN2B—Axon guidance—ACTG1—acquired immunodeficiency syndrome	7.38e-05	0.00872	CbGpPWpGaD
Pethidine—OPRK1—Peptide GPCRs—CCR5—acquired immunodeficiency syndrome	7.34e-05	0.00867	CbGpPWpGaD
Pethidine—OPRM1—Peptide ligand-binding receptors—CCL4—acquired immunodeficiency syndrome	7.33e-05	0.00866	CbGpPWpGaD
Pethidine—OPRM1—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	6.83e-05	0.00807	CbGpPWpGaD
Pethidine—OPRK1—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	6.43e-05	0.0076	CbGpPWpGaD
Pethidine—SLC6A4—Monoamine Transport—TNF—acquired immunodeficiency syndrome	6.32e-05	0.00747	CbGpPWpGaD
Pethidine—GRIN1—SIDS Susceptibility Pathways—IL10—acquired immunodeficiency syndrome	6.24e-05	0.00737	CbGpPWpGaD
Pethidine—OPRM1—Peptide GPCRs—CCR5—acquired immunodeficiency syndrome	6.2e-05	0.00733	CbGpPWpGaD
Pethidine—GRIN2C—Alzheimers Disease—TNF—acquired immunodeficiency syndrome	6.14e-05	0.00726	CbGpPWpGaD
Pethidine—OPRK1—Peptide ligand-binding receptors—CCL3—acquired immunodeficiency syndrome	5.92e-05	0.007	CbGpPWpGaD
Pethidine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	5.82e-05	0.00687	CbGpPWpGaD
Pethidine—OPRM1—TCR Signaling Pathway—CD8A—acquired immunodeficiency syndrome	5.8e-05	0.00685	CbGpPWpGaD
Pethidine—GRIN2D—Alzheimers Disease—TNF—acquired immunodeficiency syndrome	5.71e-05	0.00675	CbGpPWpGaD
Pethidine—SLC6A2—Monoamine Transport—TNF—acquired immunodeficiency syndrome	5.44e-05	0.00642	CbGpPWpGaD
Pethidine—OPRM1—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	5.43e-05	0.00642	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—ACTG1—acquired immunodeficiency syndrome	5.4e-05	0.00638	CbGpPWpGaD
Pethidine—OPRK1—Peptide ligand-binding receptors—CCR2—acquired immunodeficiency syndrome	5.36e-05	0.00633	CbGpPWpGaD
Pethidine—OPRM1—TCR Signaling Pathway—CCR5—acquired immunodeficiency syndrome	5.3e-05	0.00627	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—ACTG1—acquired immunodeficiency syndrome	5.27e-05	0.00622	CbGpPWpGaD
Pethidine—OPRK1—Peptide ligand-binding receptors—CXCR4—acquired immunodeficiency syndrome	5.04e-05	0.00595	CbGpPWpGaD
Pethidine—OPRK1—Peptide ligand-binding receptors—CXCL12—acquired immunodeficiency syndrome	5.04e-05	0.00595	CbGpPWpGaD
Pethidine—OPRM1—Peptide ligand-binding receptors—CCL3—acquired immunodeficiency syndrome	5.01e-05	0.00591	CbGpPWpGaD
Pethidine—ALB—Vitamin B12 Metabolism—CCL5—acquired immunodeficiency syndrome	4.96e-05	0.00587	CbGpPWpGaD
Pethidine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	4.91e-05	0.00581	CbGpPWpGaD
Pethidine—OPRK1—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	4.9e-05	0.00579	CbGpPWpGaD
Pethidine—SLC6A3—Monoamine Transport—TNF—acquired immunodeficiency syndrome	4.82e-05	0.00569	CbGpPWpGaD
Pethidine—GRIN2A—Alzheimers Disease—TNF—acquired immunodeficiency syndrome	4.69e-05	0.00554	CbGpPWpGaD
Pethidine—SLC6A4—SIDS Susceptibility Pathways—IL10—acquired immunodeficiency syndrome	4.68e-05	0.00553	CbGpPWpGaD
Pethidine—GRIN1—Spinal Cord Injury—IFNG—acquired immunodeficiency syndrome	4.59e-05	0.00542	CbGpPWpGaD
Pethidine—OPRM1—Peptide ligand-binding receptors—CCR2—acquired immunodeficiency syndrome	4.53e-05	0.00535	CbGpPWpGaD
Pethidine—OPRK1—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	4.52e-05	0.00534	CbGpPWpGaD
Pethidine—OPRK1—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	4.43e-05	0.00523	CbGpPWpGaD
Pethidine—OPRM1—Peptide ligand-binding receptors—CXCL12—acquired immunodeficiency syndrome	4.26e-05	0.00503	CbGpPWpGaD
Pethidine—OPRM1—Peptide ligand-binding receptors—CXCR4—acquired immunodeficiency syndrome	4.26e-05	0.00503	CbGpPWpGaD
Pethidine—OPRK1—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	4.25e-05	0.00502	CbGpPWpGaD
Pethidine—OPRK1—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	4.25e-05	0.00502	CbGpPWpGaD
Pethidine—OPRK1—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	4.19e-05	0.00495	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	4.15e-05	0.0049	CbGpPWpGaD
Pethidine—OPRM1—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	4.14e-05	0.00489	CbGpPWpGaD
Pethidine—GRIN1—Alzheimers Disease—TNF—acquired immunodeficiency syndrome	4.09e-05	0.00483	CbGpPWpGaD
Pethidine—GRIN1—Spinal Cord Injury—IL2—acquired immunodeficiency syndrome	4.08e-05	0.00481	CbGpPWpGaD
Pethidine—GRIN2B—Alzheimers Disease—TNF—acquired immunodeficiency syndrome	3.99e-05	0.00471	CbGpPWpGaD
Pethidine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	3.97e-05	0.00469	CbGpPWpGaD
Pethidine—OPRK1—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	3.94e-05	0.00466	CbGpPWpGaD
Pethidine—ALB—Folate Metabolism—IL4—acquired immunodeficiency syndrome	3.91e-05	0.00462	CbGpPWpGaD
Pethidine—OPRK1—Peptide ligand-binding receptors—CCL5—acquired immunodeficiency syndrome	3.83e-05	0.00453	CbGpPWpGaD
Pethidine—OPRM1—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	3.82e-05	0.00451	CbGpPWpGaD
Pethidine—OPRM1—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	3.74e-05	0.00442	CbGpPWpGaD
Pethidine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	3.59e-05	0.00424	CbGpPWpGaD
Pethidine—OPRM1—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	3.59e-05	0.00424	CbGpPWpGaD
Pethidine—OPRM1—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	3.59e-05	0.00424	CbGpPWpGaD
Pethidine—OPRM1—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	3.54e-05	0.00419	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	3.51e-05	0.00414	CbGpPWpGaD
Pethidine—OPRK1—Peptide ligand-binding receptors—CCR5—acquired immunodeficiency syndrome	3.45e-05	0.00408	CbGpPWpGaD
Pethidine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	3.38e-05	0.00399	CbGpPWpGaD
Pethidine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	3.38e-05	0.00399	CbGpPWpGaD
Pethidine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	3.36e-05	0.00397	CbGpPWpGaD
Pethidine—OPRM1—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	3.33e-05	0.00394	CbGpPWpGaD
Pethidine—OPRM1—TCR Signaling Pathway—CD4—acquired immunodeficiency syndrome	3.33e-05	0.00393	CbGpPWpGaD
Pethidine—OPRM1—Peptide ligand-binding receptors—CCL5—acquired immunodeficiency syndrome	3.24e-05	0.00383	CbGpPWpGaD
Pethidine—OPRK1—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	3.23e-05	0.00382	CbGpPWpGaD
Pethidine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	3.04e-05	0.00359	CbGpPWpGaD
Pethidine—OPRK1—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	3.03e-05	0.00357	CbGpPWpGaD
Pethidine—GRIN1—Spinal Cord Injury—TNF—acquired immunodeficiency syndrome	2.97e-05	0.00351	CbGpPWpGaD
Pethidine—OPRM1—Peptide ligand-binding receptors—CCR5—acquired immunodeficiency syndrome	2.92e-05	0.00345	CbGpPWpGaD
Pethidine—OPRK1—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	2.91e-05	0.00344	CbGpPWpGaD
Pethidine—ALB—Vitamin B12 Metabolism—IFNG—acquired immunodeficiency syndrome	2.91e-05	0.00344	CbGpPWpGaD
Pethidine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	2.85e-05	0.00337	CbGpPWpGaD
Pethidine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	2.85e-05	0.00337	CbGpPWpGaD
Pethidine—OPRK1—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	2.74e-05	0.00323	CbGpPWpGaD
Pethidine—OPRM1—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	2.73e-05	0.00323	CbGpPWpGaD
Pethidine—OPRK1—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	2.7e-05	0.00319	CbGpPWpGaD
Pethidine—OPRK1—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	2.57e-05	0.00304	CbGpPWpGaD
Pethidine—OPRK1—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	2.57e-05	0.00304	CbGpPWpGaD
Pethidine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	2.57e-05	0.00304	CbGpPWpGaD
Pethidine—OPRM1—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	2.56e-05	0.00302	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	2.51e-05	0.00297	CbGpPWpGaD
Pethidine—OPRM1—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	2.46e-05	0.00291	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	2.45e-05	0.00289	CbGpPWpGaD
Pethidine—GRIN1—Spinal Cord Injury—IL6—acquired immunodeficiency syndrome	2.4e-05	0.00283	CbGpPWpGaD
Pethidine—GRIN1—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	2.37e-05	0.00281	CbGpPWpGaD
Pethidine—ALB—Folate Metabolism—IFNG—acquired immunodeficiency syndrome	2.37e-05	0.0028	CbGpPWpGaD
Pethidine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	2.32e-05	0.00274	CbGpPWpGaD
Pethidine—OPRM1—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	2.31e-05	0.00273	CbGpPWpGaD
Pethidine—OPRM1—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	2.28e-05	0.0027	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	2.27e-05	0.00268	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	2.26e-05	0.00267	CbGpPWpGaD
Pethidine—OPRM1—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	2.17e-05	0.00257	CbGpPWpGaD
Pethidine—OPRM1—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	2.17e-05	0.00257	CbGpPWpGaD
Pethidine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	2.17e-05	0.00257	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	2.12e-05	0.00251	CbGpPWpGaD
Pethidine—ALB—Folate Metabolism—IL2—acquired immunodeficiency syndrome	2.1e-05	0.00248	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	2.07e-05	0.00245	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	2.03e-05	0.00239	CbGpPWpGaD
Pethidine—OPRK1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	1.96e-05	0.00231	CbGpPWpGaD
Pethidine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	1.96e-05	0.00231	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	1.92e-05	0.00227	CbGpPWpGaD
Pethidine—GRIN1—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	1.92e-05	0.00226	CbGpPWpGaD
Pethidine—ALB—Vitamin B12 Metabolism—TNF—acquired immunodeficiency syndrome	1.88e-05	0.00222	CbGpPWpGaD
Pethidine—ALB—Selenium Micronutrient Network—IFNG—acquired immunodeficiency syndrome	1.88e-05	0.00222	CbGpPWpGaD
Pethidine—OPRM1—TCR Signaling Pathway—IL6—acquired immunodeficiency syndrome	1.8e-05	0.00213	CbGpPWpGaD
Pethidine—SLC6A4—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	1.78e-05	0.0021	CbGpPWpGaD
Pethidine—OPRK1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	1.76e-05	0.00208	CbGpPWpGaD
Pethidine—SLC6A2—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	1.72e-05	0.00204	CbGpPWpGaD
Pethidine—OPRM1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	1.65e-05	0.00195	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	1.55e-05	0.00183	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	1.55e-05	0.00183	CbGpPWpGaD
Pethidine—ALB—Folate Metabolism—TNF—acquired immunodeficiency syndrome	1.53e-05	0.00181	CbGpPWpGaD
Pethidine—SLC6A3—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	1.53e-05	0.0018	CbGpPWpGaD
Pethidine—ALB—Vitamin B12 Metabolism—IL6—acquired immunodeficiency syndrome	1.52e-05	0.00179	CbGpPWpGaD
Pethidine—ALB—Platelet activation, signaling and aggregation—CSF2—acquired immunodeficiency syndrome	1.51e-05	0.00179	CbGpPWpGaD
Pethidine—OPRM1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	1.49e-05	0.00176	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	1.48e-05	0.00175	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	1.48e-05	0.00175	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	1.45e-05	0.00172	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	1.45e-05	0.00172	CbGpPWpGaD
Pethidine—SLC6A4—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	1.44e-05	0.0017	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	1.4e-05	0.00166	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—TAT—acquired immunodeficiency syndrome	1.4e-05	0.00166	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	1.34e-05	0.00159	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	1.32e-05	0.00156	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	1.32e-05	0.00156	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	1.31e-05	0.00155	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	1.31e-05	0.00154	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	1.25e-05	0.00148	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	1.25e-05	0.00148	CbGpPWpGaD
Pethidine—ALB—Folate Metabolism—IL6—acquired immunodeficiency syndrome	1.24e-05	0.00146	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	1.23e-05	0.00145	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	1.23e-05	0.00145	CbGpPWpGaD
Pethidine—ALB—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	1.22e-05	0.00144	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—AGPS—acquired immunodeficiency syndrome	1.19e-05	0.00141	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	1.19e-05	0.0014	CbGpPWpGaD
Pethidine—ALB—Metabolism—TAT—acquired immunodeficiency syndrome	1.18e-05	0.0014	CbGpPWpGaD
Pethidine—SLC6A4—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	1.17e-05	0.00139	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	1.13e-05	0.00134	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	1.12e-05	0.00132	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	1.12e-05	0.00132	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.11e-05	0.00131	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.09e-05	0.00129	CbGpPWpGaD
Pethidine—GRIN1—Axon guidance—IL6—acquired immunodeficiency syndrome	1.07e-05	0.00126	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—TAT—acquired immunodeficiency syndrome	1.06e-05	0.00125	CbGpPWpGaD
Pethidine—GRIN2B—Axon guidance—IL6—acquired immunodeficiency syndrome	1.04e-05	0.00123	CbGpPWpGaD
Pethidine—ALB—Metabolism—AGPS—acquired immunodeficiency syndrome	1e-05	0.00119	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1e-05	0.00119	CbGpPWpGaD
Pethidine—ALB—Hemostasis—IFNA1—acquired immunodeficiency syndrome	9.97e-06	0.00118	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	9.96e-06	0.00118	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	9.89e-06	0.00117	CbGpPWpGaD
Pethidine—ALB—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	9.82e-06	0.00116	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—TAT—acquired immunodeficiency syndrome	9.76e-06	0.00115	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—TNF—acquired immunodeficiency syndrome	9.44e-06	0.00112	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	9.35e-06	0.0011	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	9.21e-06	0.00109	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—TNF—acquired immunodeficiency syndrome	9.2e-06	0.00109	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	9.17e-06	0.00108	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	9.05e-06	0.00107	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—AGPS—acquired immunodeficiency syndrome	9.02e-06	0.00107	CbGpPWpGaD
Pethidine—SLC6A2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	8.75e-06	0.00103	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	8.49e-06	0.001	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	8.42e-06	0.000995	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	8.36e-06	0.000988	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—AGPS—acquired immunodeficiency syndrome	8.3e-06	0.00098	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	8.29e-06	0.00098	CbGpPWpGaD
Pethidine—ALB—Platelet activation, signaling and aggregation—IL2—acquired immunodeficiency syndrome	8e-06	0.000945	CbGpPWpGaD
Pethidine—ALB—Hemostasis—CSF2—acquired immunodeficiency syndrome	7.8e-06	0.000921	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	7.8e-06	0.000921	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	7.8e-06	0.000921	CbGpPWpGaD
Pethidine—SLC6A3—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	7.76e-06	0.000916	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	7.75e-06	0.000916	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	7.65e-06	0.000903	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—IL6—acquired immunodeficiency syndrome	7.62e-06	0.0009	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—IL6—acquired immunodeficiency syndrome	7.43e-06	0.000878	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	7.01e-06	0.000828	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	6.59e-06	0.000779	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	6.59e-06	0.000779	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—TAT—acquired immunodeficiency syndrome	6.38e-06	0.000754	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	5.93e-06	0.000701	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	5.84e-06	0.00069	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	5.76e-06	0.00068	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—AGPS—acquired immunodeficiency syndrome	5.42e-06	0.000641	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	5.34e-06	0.000631	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	5.23e-06	0.000618	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	5.01e-06	0.000592	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	4.94e-06	0.000583	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	4.86e-06	0.000575	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	4.52e-06	0.000534	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	4.42e-06	0.000522	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	4.15e-06	0.000491	CbGpPWpGaD
Pethidine—ALB—Hemostasis—IL2—acquired immunodeficiency syndrome	4.12e-06	0.000487	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.09e-06	0.000365	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.07e-06	0.000363	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.61e-06	0.000308	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	2.6e-06	0.000307	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—ALB—acquired immunodeficiency syndrome	2.45e-06	0.000289	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—ALB—acquired immunodeficiency syndrome	1.85e-06	0.000219	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.82e-06	0.000214	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—ALB—acquired immunodeficiency syndrome	1.7e-06	0.000201	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.53e-06	0.000181	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—ALB—acquired immunodeficiency syndrome	1.11e-06	0.000131	CbGpPWpGaD
